Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Pharmaceutics
|
February 25, 2023
Cabazitaxel-Loaded Nanoparticles Reduce the Invasiveness in Metastatic Prostate Cancer Cells: Beyond the Classical Taxane Function
Jana B Lampe, Priyanka P Desai, Amit K Tripathi, et al.
Pharmaceutics
|
January 21, 2022
Novel Use of Hypoxia-Inducible Polymerizable Protein to Augment Chemotherapy for Pancreatic Cancer
Andrew Gdowski, Hamed Hayatshahi, Rafal Fudala, et al.
Current Pharmaceutical Biotechnology
|
February 21, 2012
Fluorescence detection of MMP-9. II. Ratiometric FRET-based sensing with dually labeled specific peptide
Rafal Fudala, Ryan Rich, Anindita Mukerjee, et al.
Anticancer Research
|
April 19, 2011
Differential distribution of intravenous curcumin formulations in the rat brain
Simon S Chiu, Edmund Lui, Muhammed Majeed, et al.
ACS Applied Nano Materials
|
February 15, 2021
Bioinspired Nanoparticles Engineered for Enhanced Delivery to the Bone
Andrew S Gdowski, Jana B Lampe, Victor J T Lin, et al.
Cell Death & Disease
|
March 30, 2013
Influenza A virus nucleoprotein induces apoptosis in human airway epithelial cells: implications of a novel interaction between nucleoprotein and host protein Clusterin
S Tripathi, J Batra, W Cao, et al.
RSC Pharmaceutics
|
October 7, 2024
Prodrug nanotherapy demonstrates <i>in vivo</i> anticryptosporidial efficacy in a mouse model of chronic <i>Cryptosporidium</i> infection
Amalendu P Ranjan, Daniel J Czyzyk, Griselle Martinez-Traverso, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 15, 2024
Proof-of-concept studies with a computationally designed M<sup>pro</sup> inhibitor as a synergistic combination regimen alternative to Paxlovid
Christina Papini, Irfan Ullah, Amalendu P Ranjan, et al.
Molecular Ecology Resources
|
January 15, 2013
A 34K SNP genotyping array for Populus trichocarpa: design, application to the study of natural populations and transferability to other Populus species
A Geraldes, S P Difazio, G T Slavov, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 2025
A Phase II, Randomized, open-label study to evaluate low-dose Pembrolizumab plus Chemotherapy vs Chemotherapy as Neoadjuvant Therapy for localized Triple Negative Breast Cancer (TNBC). [PLANeT Trial - Pembrolizumab Low Dose in Addition to NACT in TNBC]
A Arora, H Bhaskarane, G Tansir, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Pharmaceutics
|
February 25, 2023
Cabazitaxel-Loaded Nanoparticles Reduce the Invasiveness in Metastatic Prostate Cancer Cells: Beyond the Classical Taxane Function
Jana B Lampe, Priyanka P Desai, Amit K Tripathi, et al.
Pharmaceutics
|
January 21, 2022
Novel Use of Hypoxia-Inducible Polymerizable Protein to Augment Chemotherapy for Pancreatic Cancer
Andrew Gdowski, Hamed Hayatshahi, Rafal Fudala, et al.
Current Pharmaceutical Biotechnology
|
February 21, 2012
Fluorescence detection of MMP-9. II. Ratiometric FRET-based sensing with dually labeled specific peptide
Rafal Fudala, Ryan Rich, Anindita Mukerjee, et al.
Anticancer Research
|
April 19, 2011
Differential distribution of intravenous curcumin formulations in the rat brain
Simon S Chiu, Edmund Lui, Muhammed Majeed, et al.
ACS Applied Nano Materials
|
February 15, 2021
Bioinspired Nanoparticles Engineered for Enhanced Delivery to the Bone
Andrew S Gdowski, Jana B Lampe, Victor J T Lin, et al.
Cell Death & Disease
|
March 30, 2013
Influenza A virus nucleoprotein induces apoptosis in human airway epithelial cells: implications of a novel interaction between nucleoprotein and host protein Clusterin
S Tripathi, J Batra, W Cao, et al.
RSC Pharmaceutics
|
October 7, 2024
Prodrug nanotherapy demonstrates <i>in vivo</i> anticryptosporidial efficacy in a mouse model of chronic <i>Cryptosporidium</i> infection
Amalendu P Ranjan, Daniel J Czyzyk, Griselle Martinez-Traverso, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 15, 2024
Proof-of-concept studies with a computationally designed M<sup>pro</sup> inhibitor as a synergistic combination regimen alternative to Paxlovid
Christina Papini, Irfan Ullah, Amalendu P Ranjan, et al.
Molecular Ecology Resources
|
January 15, 2013
A 34K SNP genotyping array for Populus trichocarpa: design, application to the study of natural populations and transferability to other Populus species
A Geraldes, S P Difazio, G T Slavov, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 2025
A Phase II, Randomized, open-label study to evaluate low-dose Pembrolizumab plus Chemotherapy vs Chemotherapy as Neoadjuvant Therapy for localized Triple Negative Breast Cancer (TNBC). [PLANeT Trial - Pembrolizumab Low Dose in Addition to NACT in TNBC]
A Arora, H Bhaskarane, G Tansir, et al.
Page
of 10